Company intelligence / Profile preview

BioSimilar Sciences

Aguadilla, Puerto Rico, United States

Ownership: Private
Development stage: Other

Overview

Biosimilar Sciences PR LLC is a global biotechnology company dedicated to developing and commercializing high-quality, affordable biosimilar therapeutics. Headquartered in Aguadilla, Puerto Rico, the company focuses on critical therapeutic areas such as oncology, immunology, and metabolic disorders. Its pipeline includes biosimilars for blockbuster biologics like Neupogen (filgrastim), Neulasta (pegfilgrastim), Aranesp (darbepoetin alfa), and Humira (adalimumab). Through strategic partnerships with OcyonBio and Ipca Laboratories, Biosimilar Sciences leverages advanced sterile manufacturing capabilities and regulatory expertise to expand patient access to life-saving biologic medicines across North America and global markets.

Therapeutic areas: OncologyGastroenterologyImmunologyDermatologyInfectious DiseasesHematology
Modalities: BiologicRecombinant proteinMonoclonal antibodyVaccineCell therapy
Industry: Biotech

Partnerships

OcyonBioIpca LaboratoriesBiosimilar Solutions

Beyond the preview

Go deeper on BioSimilar Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSimilar Sciences.

Explore the full profile